Immunogenicity and safety of BNT162b2 COVID-19 vaccine in a chronic lymphocytic leukaemia patient

Chiara Agrati; Concetta Castilletti; Alessandra Sacchi; Francesca Colavita; Maria Rosaria Capobianchi; Vincenzo Puro; Emanuele Nicastri; Giuseppe Ippolito; Michele Bibas

doi:10.1111/jcmm.16565

Immunogenicity and safety of BNT162b2 COVID-19 vaccine in a chronic lymphocytic leukaemia patient

Chiara Agrati, Concetta Castilletti, Alessandra Sacchi, Francesca Colavita, Maria Rosaria Capobianchi, Vincenzo Puro, Emanuele Nicastri, Giuseppe Ippolito, Michele Bibas

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1-3
Number of pages	3
Journal	Journal of Cellular and Molecular Medicine
DOIs	https://doi.org/10.1111/jcmm.16565
Publication status	Accepted/In press - 2021

ASJC Scopus subject areas

Molecular Medicine
Cell Biology

Access to Document

10.1111/jcmm.16565

Cite this

@article{a06c13ff7eb649238c0f1c65a95bce49,

title = "Immunogenicity and safety of BNT162b2 COVID-19 vaccine in a chronic lymphocytic leukaemia patient",

author = "Chiara Agrati and Concetta Castilletti and Alessandra Sacchi and Francesca Colavita and Capobianchi, {Maria Rosaria} and Vincenzo Puro and Emanuele Nicastri and Giuseppe Ippolito and Michele Bibas",

note = "Funding Information: This work was supported by Italian Ministry of Health (Line 1 Ricerca Corrente, COVID‐2020‐12371817, COVID‐2020‐12371735) ",

year = "2021",

doi = "10.1111/jcmm.16565",

language = "English",

pages = "1--3",

journal = "Journal of Cellular and Molecular Medicine",

issn = "1582-1838",

publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Immunogenicity and safety of BNT162b2 COVID-19 vaccine in a chronic lymphocytic leukaemia patient

AU - Agrati, Chiara

AU - Castilletti, Concetta

AU - Sacchi, Alessandra

AU - Colavita, Francesca

AU - Capobianchi, Maria Rosaria

AU - Puro, Vincenzo

AU - Nicastri, Emanuele

AU - Ippolito, Giuseppe

AU - Bibas, Michele

N1 - Funding Information: This work was supported by Italian Ministry of Health (Line 1 Ricerca Corrente, COVID‐2020‐12371817, COVID‐2020‐12371735)

PY - 2021

Y1 - 2021

UR - http://www.scopus.com/inward/record.url?scp=85106238283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85106238283&partnerID=8YFLogxK

U2 - 10.1111/jcmm.16565

DO - 10.1111/jcmm.16565

M3 - Letter

AN - SCOPUS:85106238283

SP - 1

EP - 3

JO - Journal of Cellular and Molecular Medicine

JF - Journal of Cellular and Molecular Medicine

SN - 1582-1838

ER -

Immunogenicity and safety of BNT162b2 COVID-19 vaccine in a chronic lymphocytic leukaemia patient

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this